Quick Answer
Hyperbaric oxygen therapy for autism has been tested in randomized controlled trials, and the results do **not* support it as an effective treatment. The largest and best-designed trial (Granpeesheh et al., 2010) found no significant difference between HBOT and sham treatment on core autism symptoms. The FDA has specifically warned parents about unproven hyperbaric therapy claims for autism. This article exists to give parents an honest, evidence-based answer — not to sell a treatment we don’t believe is supported by the science.
Why This Topic Requires Extra Care
Autism is one of the most searched conditions alongside “hyperbaric oxygen therapy,” and it’s also one of the areas where marketing claims have run furthest ahead of the evidence. Parents of autistic children are often navigating a confusing landscape of interventions, some well-supported (speech therapy, occupational therapy, ABA) and some not — and HBOT has unfortunately been marketed aggressively in the latter category by some providers.
We think parents deserve a straight answer, even though we manufacture hyperbaric equipment. So here it is.
What the Research Actually Shows
| Study | Design | Sample Size | Pressure | Result |
|---|---|---|---|---|
| Rossignol et al. (2009), BMC Pediatrics | Randomized, controlled | 62 children | 1.3 ATA (24% O₂) | Some improvement reported in secondary behavioral measures; methodology later criticized |
| Granpeesheh et al. (2010), Research in Autism Spectrum Disorders* | Randomized, double-blind, placebo-controlled | 46 children | 1.3 ATA vs. sham | **No significant difference* between HBOT and sham treatment on any core autism measure |
| Sampanthavivat et al. (2012), Diving and Hyperbaric Medicine* | Randomized, sham-controlled | 60 children | 1.3 ATA | No significant improvement over sham on standardized autism rating scales |
| Cochrane Review (Xiong et al., 2016 update) | Systematic review of RCTs | Multiple trials | Various | Insufficient evidence to support HBOT as an autism intervention |
The Granpeesheh trial is particularly important because it was specifically designed to address the methodological weaknesses of the earlier Rossignol study — and when the design was tightened with a proper sham control, the apparent benefit disappeared. This is a common and important pattern in medical research: early, less rigorous studies sometimes show effects that don’t hold up once better-controlled trials are run.
What Regulatory Bodies Have Said
The U.S. FDA has issued public warnings specifically about hyperbaric oxygen therapy being marketed for autism, stating that HBOT has not been proven safe or effective for this use and cautioning parents against providers making such claims. This is a stronger and more specific warning than exists for most other off-label HBOT applications discussed elsewhere on this site — which is why we’re treating this topic differently here.
Why the Marketing Persists Despite the Evidence
Autism is a lifelong condition with no single approved medical cure, and parents are — reasonably — motivated to try interventions that offer hope. Some private clinics and wellness centers continue marketing HBOT for autism using older, less rigorous studies or anecdotal testimonials, without disclosing the negative results from better-designed trials. This is a pattern regulatory bodies have flagged repeatedly, not just for HBOT but across various unproven autism interventions.
If a provider is recommending HBOT specifically to treat autism symptoms and isn’t discussing the Granpeesheh trial results or the FDA’s warning, that’s worth asking about directly.
What We Actually Sell — And What We Don’t Claim
We manufacture mild hyperbaric chambers (1.1–1.7 atm) for general wellness, home relaxation, spa use, and altitude recovery. **We do not market our equipment as an autism treatment, and we don’t recommend it as one.* Some families of autistic children do use mild chambers as part of a broader sensory or relaxation routine — similar to how they might use a weighted blanket or a quiet room — but that is categorically different from claiming a therapeutic effect on autism symptoms, and we won’t blur that line.
If you’re a parent researching autism interventions, we’d encourage prioritizing therapies with a stronger evidence base — speech and language therapy, occupational therapy, and applied behavior analysis (ABA) all have substantially more research support than HBOT does for this specific population.
For any family that independently decides a quiet, low-stimulation chamber environment fits into their child’s broader sensory routine, our AURA One is built for calm, simple home use — but we want to be clear this is a general wellness product, not something we position or sell as an autism treatment.
FAQ
Q: Does hyperbaric oxygen therapy treat autism?
No. The best-designed randomized controlled trial (Granpeesheh et al., 2010) found no significant benefit over sham treatment. A 2016 Cochrane systematic review concluded there is insufficient evidence to support HBOT as an autism intervention.
Q: Has the FDA warned about HBOT for autism specifically?
Yes. The FDA has publicly cautioned parents about hyperbaric oxygen therapy being marketed for autism, stating it has not been proven safe or effective for this use.
Q: Why did an earlier study (Rossignol 2009) show positive results?
That trial had methodological limitations that were addressed in the later, better-controlled Granpeesheh (2010) study — which found no significant effect. This is a common pattern where early positive findings don’t replicate under more rigorous trial design.
Q: What autism interventions have stronger evidence?
Speech and language therapy, occupational therapy, and applied behavior analysis (ABA) all have substantially more research support for autism than hyperbaric oxygen therapy. A developmental pediatrician or autism specialist can help build an appropriate treatment plan.
Q: Is it safe to use a mild hyperbaric chamber with an autistic child for general relaxation?
This is a decision to make with your child’s pediatrician, considering their specific sensory needs and any medical history. It should not be pursued with the expectation of treating core autism symptoms, as the evidence does not support that outcome.
This article is for educational purposes only and is not medical advice. Multiple randomized controlled trials have found no significant benefit of HBOT for core autism symptoms, and the FDA has issued specific warnings about this marketing claim. HyperbaricO2Care manufactures mild hyperbaric chambers (1.1–1.7 atm) intended for general wellness use and does not market or recommend its equipment as an autism treatment. Parents should consult a developmental pediatrician or autism specialist for evidence-based intervention planning. References: Granpeesheh et al., Research in Autism Spectrum Disorders (2010); Sampanthavivat et al., Diving and Hyperbaric Medicine (2012); Xiong et al., Cochrane Database of Systematic Reviews (2016); U.S. FDA Consumer Update on Hyperbaric Oxygen Therapy.*
Explore our chambers: AURA One (Home) · View All Products · About Us
Pingback: HBOT for Skin Health: Wrinkles, Collagen & Recovery